Pretransplant hyperferritinemia has no effect on the outcome of myeloablative cord blood transplantation for acute leukemia and myelodysplastic syndrome

Ann Hematol. 2014 Jun;93(6):1071-2. doi: 10.1007/s00277-013-1932-9. Epub 2013 Oct 19.

Authors

Takaaki Konuma¹, Seiko Kato, Maki Oiwa-Monna, Arinobu Tojo, Satoshi Takahashi

Affiliation

¹ Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan, [email protected].

PMID: 24141336
DOI: 10.1007/s00277-013-1932-9

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Cord Blood Stem Cell Transplantation*
Ferritins / blood*
Graft vs Host Disease / epidemiology
Humans
Inflammation / blood
Iron Overload / blood
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute / blood
Leukemia, Myeloid, Acute / surgery*
Middle Aged
Myeloablative Agonists / therapeutic use
Myelodysplastic Syndromes / blood
Myelodysplastic Syndromes / surgery*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
Proportional Hazards Models
Retrospective Studies
Treatment Outcome
Whole-Body Irradiation
Young Adult

Substances

Myeloablative Agonists
Ferritins